152 related articles for article (PubMed ID: 1282575)
1. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages.
Suzawa H; Kikuchi S; Ichikawa K; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):85-90. PubMed ID: 1282575
[TBL] [Abstract][Full Text] [Related]
2. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts.
Suzawa H; Kikuchi S; Arai N; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):91-6. PubMed ID: 1282576
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tranilast, an anti-allergic drug, on the human keloid tissues].
Suzawa H; Kikuchi S; Ichikawa K; Arai N; Tazawa S; Tsuchiya O; Momose Y; Shibata N; Sugimoto C; Hamano S
Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):231-9. PubMed ID: 1376711
[TBL] [Abstract][Full Text] [Related]
4. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts.
Yamada H; Tajima S; Nishikawa T; Murad S; Pinnell SR
J Biochem; 1994 Oct; 116(4):892-7. PubMed ID: 7533764
[TBL] [Abstract][Full Text] [Related]
5. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
6. Effect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts.
Yasukawa T; Kimura H; Dong J; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Ophthalmic Res; 2002; 34(4):206-12. PubMed ID: 12297693
[TBL] [Abstract][Full Text] [Related]
7. Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1.
Yamamoto M; Yamauchi T; Okano K; Takahashi M; Watabe S; Yamamoto Y
Tohoku J Exp Med; 2009 Mar; 217(3):193-201. PubMed ID: 19282654
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tranilast, an anti-allergic drug, on carrageenin-induced granulation and capillary permeability in rats].
Suzawa H; Ichikawa K; Kikuchi S; Yamada K; Tsuchiya O; Hamano S; Komatsu H; Miyata H
Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):241-6. PubMed ID: 1376712
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes.
Roch-Arveiller M; Tissot M; Idohou N; Sarfati G; Giroud JP; Raichvarg D
Agents Actions; 1994 Nov; 43(1-2):13-6. PubMed ID: 7741033
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells.
Ikeda H; Inao M; Fujiwara K
Biochem Biophys Res Commun; 1996 Oct; 227(2):322-7. PubMed ID: 8878516
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats.
Miyazawa K; Kikuchi S; Fukuyama J; Hamano S; Ujiie A
Atherosclerosis; 1995 Dec; 118(2):213-21. PubMed ID: 8770315
[TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits interleukin-33 production by macrophages.
Hiraide S; Yanagawa Y; Iizuka K
Eur J Pharmacol; 2018 Jan; 818():235-240. PubMed ID: 29107673
[TBL] [Abstract][Full Text] [Related]
13. Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro.
Wang JY; Wicklund BH; Gustilo RB; Tsukayama DT
Biomaterials; 1996 Dec; 17(23):2233-40. PubMed ID: 8968517
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblasts.
Inoue H; Ohshima H; Kono H; Yamanaka M; Kubota T; Aihara M; Hiroi T; Yago N; Ishida H
Biochem Pharmacol; 1997 Jun; 53(12):1941-4. PubMed ID: 9256170
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effect of Tranilast on Transforming Growth Factor-Beta-Induced Protein in Granular Corneal Dystrophy Type 2 Corneal Fibroblasts.
Kim TI; Lee H; Hong HK; Kim KS; Choi SI; Maeng YS; Kim EK
Cornea; 2015 Aug; 34(8):950-8. PubMed ID: 26020822
[TBL] [Abstract][Full Text] [Related]
16. Anti-platelet action of an anti-allergic agent, N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast).
Iwasa Y; Iwasa T; Matsui K; Yoshimura T; Tanaka N; Miyazaki K
Eur J Pharmacol; 1986 Jan; 120(2):231-4. PubMed ID: 2419148
[TBL] [Abstract][Full Text] [Related]
17. Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro.
Maita E; Sato M; Yamaki K
J Periodontol; 2004 Aug; 75(8):1054-60. PubMed ID: 15455731
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis.
Capper EA; Roshak AK; Bolognese BJ; Podolin PL; Smith T; Dewitt DL; Anderson KM; Marshall LA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1061-9. PubMed ID: 11082441
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro.
Isaji M; Aruga N; Naito J; Miyata H
Life Sci; 1994; 55(15):PL287-92. PubMed ID: 7523821
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts.
Isaji M; Kikuchi S; Miyata H; Ajisawa Y; Araki-Inazawa K; Tsukamoto Y; Amano Y
Cornea; 2000 May; 19(3):364-8. PubMed ID: 10832700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
